Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SpringWorks, Janssen to Evaluate Nirogacestat with Teclistamab for Multiple Myeloma

americanpharmaceuticalreviewSeptember 21, 2020

Tag: SpringWorks , Janssen , Teclistamab , Nirogacestat , multiple myeloma

PharmaSources Customer Service